Shaila Misri

Summary

Affiliation: University of British Columbia
Country: Canada

Publications

  1. doi request reprint Biopsychosocial determinants of treatment outcome for mood and anxiety disorders up to 8 months postpartum
    Shaila Misri
    Reproductive Mental Health Program, St Paul s Hospital, Vancouver, BC, Canada
    Arch Womens Ment Health 15:313-6. 2012
  2. ncbi request reprint Relation between prenatal maternal mood and anxiety and neonatal health
    Shaila Misri
    Department of Psychiatry, University of British Columbia, Vancouver
    Can J Psychiatry 49:684-9. 2004
  3. ncbi request reprint Antenatal depression and anxiety affect postpartum parenting stress: a longitudinal, prospective study
    Shaila Misri
    Department of Psychiatry and Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia
    Can J Psychiatry 55:222-8. 2010
  4. doi request reprint Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure
    Tim F Oberlander
    Department of Pediatrics, UBC, Vancouver, BC, Canada V6H 3V4
    Early Hum Dev 84:689-97. 2008
  5. ncbi request reprint Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications
    Shaila Misri
    Reproductive Mental Health Program, St Paul s Hospital, Rm 2B 185, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada
    Am J Psychiatry 163:1026-32. 2006
  6. doi request reprint Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study
    Tim F Oberlander
    Early Human Experience Unit, Centre for Community Child Health Research, Vancouver, BC, Canada
    Br J Psychiatry 192:338-43. 2008
  7. ncbi request reprint Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure
    Tim F Oberlander
    Department of Pediatrics, Centre for Community Child Health Research, University of British Columbia, L408 4480 Oak Street, Vancouver, BC, Canada V6H 3V4
    J Clin Psychiatry 65:230-7. 2004
  8. doi request reprint Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age
    Tim F Oberlander
    Early Human Experience Unit, Developmental Neurosciences and Child Health, and Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada
    Arch Pediatr Adolesc Med 164:444-51. 2010
  9. doi request reprint Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data
    Tim F Oberlander
    Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada
    Birth Defects Res B Dev Reprod Toxicol 83:68-76. 2008
  10. ncbi request reprint Treatment of perinatal mood and anxiety disorders: a review
    Shaila Misri
    University of British Columbia, Vancouver
    Can J Psychiatry 52:489-98. 2007

Detail Information

Publications26

  1. doi request reprint Biopsychosocial determinants of treatment outcome for mood and anxiety disorders up to 8 months postpartum
    Shaila Misri
    Reproductive Mental Health Program, St Paul s Hospital, Vancouver, BC, Canada
    Arch Womens Ment Health 15:313-6. 2012
    ..Biological and psychosocial variables predicted pharmacological treatment outcome in postpartum-depressed and anxious women...
  2. ncbi request reprint Relation between prenatal maternal mood and anxiety and neonatal health
    Shaila Misri
    Department of Psychiatry, University of British Columbia, Vancouver
    Can J Psychiatry 49:684-9. 2004
    ..To examine the relation between the mood and anxiety of pregnant, psychiatrically treated women and neonatal health outcomes after birth...
  3. ncbi request reprint Antenatal depression and anxiety affect postpartum parenting stress: a longitudinal, prospective study
    Shaila Misri
    Department of Psychiatry and Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia
    Can J Psychiatry 55:222-8. 2010
    ..We studied the effect of antenatal depression and anxiety and treatment with selective serotonin reuptake inhibitors and selective norepinephrine reuptake inhibitors (antidepressants [ADs]) on postpartum parenting stress...
  4. doi request reprint Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure
    Tim F Oberlander
    Department of Pediatrics, UBC, Vancouver, BC, Canada V6H 3V4
    Early Hum Dev 84:689-97. 2008
    ....
  5. ncbi request reprint Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications
    Shaila Misri
    Reproductive Mental Health Program, St Paul s Hospital, Rm 2B 185, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada
    Am J Psychiatry 163:1026-32. 2006
    ..The authors had previously reported the effects of prenatal medication exposure in this same cohort when they were newborns and infants at 3 and 8 months of age...
  6. doi request reprint Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study
    Tim F Oberlander
    Early Human Experience Unit, Centre for Community Child Health Research, Vancouver, BC, Canada
    Br J Psychiatry 192:338-43. 2008
    ..Late-gestational serotonin reuptake inhibitor (SRI) exposure has been linked to adverse neonatal outcomes; however, the impact of timing and duration of exposure is unknown...
  7. ncbi request reprint Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure
    Tim F Oberlander
    Department of Pediatrics, Centre for Community Child Health Research, University of British Columbia, L408 4480 Oak Street, Vancouver, BC, Canada V6H 3V4
    J Clin Psychiatry 65:230-7. 2004
    ..Also, this study explores relationships between neonatal outcomes and medication levels during pregnancy, at delivery, and in the newborn period...
  8. doi request reprint Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age
    Tim F Oberlander
    Early Human Experience Unit, Developmental Neurosciences and Child Health, and Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada
    Arch Pediatr Adolesc Med 164:444-51. 2010
    ....
  9. doi request reprint Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data
    Tim F Oberlander
    Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada
    Birth Defects Res B Dev Reprod Toxicol 83:68-76. 2008
    ..To determine a population-based incidence of congenital anomalies following prenatal exposure to serotonin reuptake inhibitor (SRI) antidepressants used alone and in combination with a benzodiazepines (BZ)...
  10. ncbi request reprint Treatment of perinatal mood and anxiety disorders: a review
    Shaila Misri
    University of British Columbia, Vancouver
    Can J Psychiatry 52:489-98. 2007
    ....
  11. ncbi request reprint Quetiapine augmentation in lactation: a series of case reports
    Shaila Misri
    The University of British Columbia, Vancouver, BC, Canada
    J Clin Psychopharmacol 26:508-11. 2006
    ..These results should be interpreted with caution, and vigilance should be exercised when advising women on combinations of medications for severe mental illness who choose to nurse...
  12. ncbi request reprint Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses
    Tim F Oberlander
    Department of Pediatrics, Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada
    Epigenetics 3:97-106. 2008
    ....
  13. pmc Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding
    John Kim
    Department of Psychiatry, University of British Columbia
    Br J Clin Pharmacol 61:155-63. 2006
    ..To compare the disposition of fluoxetine and norfluoxetine enantiomers in the mother, foetus and infant...
  14. ncbi request reprint Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy
    Tim F Oberlander
    Department of Pediatrics, Human Early Experience Unit, Centre for Community Child Health Research, Research Institute for Children s and Women s Health, University of British Columbia, 4480 Oak Street, Vancouver, BC, Canada V6 3V4
    Arch Pediatr Adolesc Med 161:22-9. 2007
    ..To evaluate attentional and activity behaviors in 4-year-olds following prenatal selective serotonin reuptake inhibitor (SSRI) exposure...
  15. ncbi request reprint The impact of treatment intervention on parenting stress in postpartum depressed mothers: a prospective study
    Shaila Misri
    BC Women s Hospital, Reproductive Mental Health Program, Vancouver, BC, Canada
    Am J Orthopsychiatry 76:115-9. 2006
    ..In addition to monitoring of depressive symptoms, routine assessment of maternal parenting qualities is recommended to ensure healthy child outcomes...
  16. ncbi request reprint Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data
    Tim F Oberlander
    Department of Pediatrics, Human Early Learning Partnership, Faculty of Graduate Studies, University of British Columbia, Vancouver
    Arch Gen Psychiatry 63:898-906. 2006
    ..Prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants and maternal depression both alter neonatal health, and distinguishing the effects of each influence remains challenging...
  17. ncbi request reprint The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial
    Shaila Misri
    Department of, Faculty of Medicine, University of British Columbia and Reproductive Mental Health Programs, St Paul s Hospital, Vancouver, British Columbia, Canada
    J Clin Psychiatry 65:1236-41. 2004
    ....
  18. doi request reprint Managing unipolar depression in pregnancy
    Julia Raudzus
    Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada
    Curr Opin Psychiatry 22:13-8. 2009
    ....
  19. ncbi request reprint Psychologic aspects of early pregnancy loss
    Diana Carter
    Departments of Psychiatry, Faculty of Medicine, University of British Columbia, Canada
    Clin Obstet Gynecol 50:154-65. 2007
    ..The course and impact of these disorders on a grieving mother and her partner are discussed and treatment recommendations are made. The psychologic effects of therapeutic abortion are also be briefly discussed...
  20. ncbi request reprint Antipsychotic medication during pregnancy and lactation in women with schizophrenia: evaluating the risk
    Sheila W Patton
    University of British Columbia, Vancouver, British Columbia
    Can J Psychiatry 47:959-65. 2002
    ....
  21. pmc Platelet serotonin levels support depression scores for women with postpartum depression
    Elisabeth Maurer-Spurej
    Canadian Blood Services, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
    J Psychiatry Neurosci 32:23-9. 2007
    ..This study examined whether a new measurement for platelet serotonin could aid in the diagnosis of postpartum depression and support the results from questionnaires...
  22. ncbi request reprint Obsessive-compulsive disorder in the postpartum: open-label trial of quetiapine augmentation
    Shaila Misri
    Department of Psychiatry, University of British Columbia, British Columbia, Canada
    J Clin Psychopharmacol 24:624-7. 2004
    ..The objective of this open-label study was to evaluate clinical response to quetiapine augmentation of SSRIs or SNRIs in treatment-resistant OCD in the postpartum...
  23. ncbi request reprint Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response
    Tim F Oberlander
    Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada
    Pediatr Res 51:443-53. 2002
    ..Possible 5HT-mediated pain inhibition, pharmacologic factors and the developmental course remain to be studied...
  24. ncbi request reprint Paroxetine use in the treatment of premenstrual dysphoric disorder
    Shaila Misri
    University of British Columbia, 2329 West Mall, Vancouver, BC, B6T 1Z4, Canada
    Womens Health (Lond Engl) 2:43-51. 2006
    ..This article reviews the properties of this medication and its use in the treatment of premenstrual dysphoric disorder...
  25. ncbi request reprint Benefits and risks to mother and infant of drug treatment for postnatal depression
    Shaila Misri
    Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada
    Drug Saf 25:903-11. 2002
    ..It is critical that healthcare providers evaluate each mother-infant dyad on an individual basis when faced with the decision to prescribe antidepressant medications during the postnatal period...
  26. ncbi request reprint Suffering in silence: the burden of perinatal depression
    Shaila Misri
    Can J Psychiatry 52:477-8. 2007